ストックスクリーナーアプリを入手
0.6674
4.38%
0.028
前日終値:
$0.6394
開ける：
$0.64
24時間の取引高:
151.43K
Relative Volume:
0.06
時価総額：
$48.02M
収益：
-
当期純損益:
$-86.08M
株価収益率:
-0.3094
EPS:
-2.1574
ネットキャッシュフロー:
$-72.06M
1週間 パフォーマンス:
+9.61%
1か月 パフォーマンス:
-4.21%
6か月 パフォーマンス:
-53.33%
1年 パフォーマンス:
-25.84%
1日の値動き範囲:
$0.6364
$0.6822
1週間の範囲:
$0.60
$0.6957
52週間の値動き範囲:
$0.3234
$2.79
Io Biotech Inc Stock (IOBT) Company Profile
IOBT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IOBT
Io Biotech Inc
|
0.6674 | 46.00M | 0 | -86.08M | -72.06M | -2.1574 |
|
VRTX
Vertex Pharmaceuticals Inc
|
476.99 | 118.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
799.17 | 81.61B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
424.91 | 53.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
812.47 | 49.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.30 | 37.34B | 447.02M | -1.18B | -906.14M | -6.1812 |
Io Biotech Inc Stock (IOBT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-30 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2025-09-30 | ダウングレード | TD Cowen | Buy → Hold |
Io Biotech Inc (IOBT) 最新ニュース
Will IO Biotech Inc. stock outperform international peers2026 world cup usa national team semifinals top scorers set piece tactics odds analysis breakdown - Улправда
IO Biotech receives Nasdaq notice for bid price noncompliance - MSN
How IO Biotech Inc. stock performs during Fed tightening cyclesVolatility Adjusted Trading & Grow Smarter With Pro-Level Research - bollywoodhelpline.com
Short Interest in IO Biotech, Inc. (NASDAQ:IOBT) Decreases By 29.2% - MarketBeat
IO Biotech (NASDAQ:IOBT) Stock Rating Lowered by Wall Street Zen - Defense World
Will IO Biotech Inc. stock reach all time highs in 2025Stock Surge & Accurate Intraday Trade Tips - Улправда
How IO Biotech Inc. stock benefits from strong dollarJuly 2025 Reactions & Smart Allocation Stock Tips - Улправда
How strong is IO Biotech Inc. stock balance sheet2025 Buyback Activity & Consistent Income Trade Ideas - Улправда
What margin trends mean for IO Biotech Inc. stockWeekly Risk Summary & AI Powered Buy/Sell Recommendations - Улправда
Will IO Biotech Inc. stock pay special dividendsPrice Action & Weekly Top Performers Watchlists - Улправда
How IO Biotech Inc. stock reacts to oil pricesJuly 2025 Highlights & Low Risk High Reward Ideas - Улправда
IO Biotech Receives Nasdaq Notice for Bid Price Noncompliance - TipRanks
IO Biotech Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView — Track All Markets
Why hedge funds are buying IO Biotech Inc. stockRecession Risk & Free Fast Entry Momentum Trade Alerts - Улправда
Why IO Biotech Inc. stock could outperform in 20252025 Short Interest & Real-Time Price Movement Reports - Улправда
What catalysts could drive IO Biotech Inc. stock higherOil Prices & Capital Protection Trading Alerts - DonanımHaber
Breakout Watch: Will IO Biotech Inc. stock pay special dividends2025 Price Action Summary & Short-Term High Return Ideas - Улправда
Institution Moves: How IO Biotech Inc. stock performs after earningsWeekly Trade Review & Daily Technical Stock Forecast Reports - Улправда
Shorts Report: Will IO Biotech Inc. stock pay special dividends2025 Bull vs Bear & Free Growth Oriented Trading Recommendations - Улправда
IO Biotech, Inc. (NASDAQ:IOBT) Receives $6.33 Average PT from Analysts - Defense World
IO Biotech Announces Publication of Five-year Clinical Outcomes of Phase 1/2 Trial in Nature Communications - The Manila Times
IO Biotech reports promising 5-year melanoma vaccine data By Investing.com - Investing.com Canada
IO Biotech reports promising 5-year melanoma vaccine data - Investing.com
IO Biotech Publishes Five-Year Results from MM1636 Trial Showing Potential of IO102-IO103 in Metastatic Melanoma Treatment - Quiver Quantitative
IO Biotech (NASDAQ: IOBT) 5-year data show 60-month OS, >53-month responses - Stock Titan
Surprises Report: Will IO Biotech Inc. stock reach all time highs in 2025 - moha.gov.vn
IO Biotech, Inc. (NASDAQ:IOBT) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Nothing is Better Than IO Biotech Inc (IOBT) stock at the moment - Setenews
What margin trends mean for IO Biotech Inc stock2025 Winners & Losers & AI Powered Trade Plan Recommendations - BỘ NỘI VỤ
IO Biotech (IOBT) Stock Analysis Report | Financials & Insights - Benzinga
How does IO Biotech Inc (IOBT) change from a tortoise to a hare? - Setenews
Research Recommendations For IO Biotech Inc (IOBT): Here is What You Should Know - fostersleader.com
Analyst Downgrade: How IO Biotech Inc. stock benefits from strong dollarJuly 2025 Movers & Free Growth Oriented Trading Recommendations - moha.gov.vn
Aug Wrap: What margin trends mean for IO Biotech Inc. stockJuly 2025 Decliners & Real-Time Volume Analysis Alerts - moha.gov.vn
IO Biotech Announces Participation in Upcoming December Investor Conferences - The Manila Times
IO Biotech (Nasdaq: IOBT) to Join Evercore, Piper Sandler December Investor Events - Stock Titan
IOBTRemeasuring Biotech Pipelines: The Valuation Signal Investors Have Been Waiting For - mx.advfn.com
It makes sense and dollars to buy IO Biotech Inc (IOBT) stock - Setenews
IO Biotech (NASDAQ:IOBT) Stock Rating Upgraded by Wall Street Zen - Defense World
Ligand Pharmaceuticals (NASDAQ:LGND) and IO Biotech (NASDAQ:IOBT) Financial Review - Defense World
IO Biotech Announces Resignation of Chief Accounting Officer - The Globe and Mail
IO Biotech announces resignation of chief accounting officer and new appointment By Investing.com - Investing.com South Africa
IO Biotech announces resignation of chief accounting officer and new appointment - Investing.com Nigeria
IO Biotech Announces Management Changes - TradingView
[8-K] IO Biotech, Inc. Reports Material Event | IOBT SEC FilingForm 8-K - Stock Titan
IO Biotech, Inc. Announces Executive Changes - MarketScreener
Can IO Biotech Inc. stock withstand economic slowdown2025 Retail Activity & Risk Controlled Daily Trade Plans - newser.com
IO Biotech’s Q3 2025: Progress in Cancer Vaccine Trials - MSN
Io Biotech Inc (IOBT) 財務データ
収益
当期純利益
現金流量
EPS
0.90%
大文字化:
|
ボリューム (24 時間):